Value proposition

Automation and standardization of cryopreservation processes for Cell Therapies

Cellulis (formerly ZF Biotox) provides disruptive cryopreservation technologies in a broad range of biotechnology fields aiming to innovate CELL THERAPY solutions, to streamline BIOPROCESSING production, to enhance BIOBANKING and to improve High Throughput Screening (HTS) campaigns.

Frozen Cells in Microplates Ready to Use., Final product formulation for cryopreserved cell therapy, and Cryopreservation of Cell Therapies